Navigation Links
SETO Holdings, Inc. Signs Letter of Intent to Dispose of all its Existing Businesses and Acquire Advanced Hearing Centers, Inc.; New Management to be Installed.
Date:3/5/2009

BRIARCLIFF MANOR, N.Y., March 5 /PRNewswire-FirstCall/ -- SETO Holdings, Inc. (Pink Sheets: SETO) announced that it signed a Letter of Intent under which it agreed in principle (1) to issue shares of its Common Stock to acquire 100% of the capital stock of Advanced Hearing Centers, Inc. ("AHC"), a Maryland corporation which provides hearing services and retails hearing aids from 11 locations in Maryland and one in Virginia, and (2) to sell all of SETO's current businesses, i.e., industrial ceramics fabrication and contract manufacturing, to Eugene Pian, SETO's President, in exchange for all the shares of SETO Common Stock he owns.

At closing, Mr. Pian's would resign as an officer and director and cease all affiliation with the public company, whose name would be changed to Lotus Holdings, Inc.; Sanjay Srivastava, Lotus' founder and CEO, would own 90% of the outstanding Common Stock of the public company and he would become President and CEO of the public company; and there would be issued and outstanding 77,923,120 shares of the public company's Common Stock, of which the public shareholders would own 7,792,312 shares, or 10% thereof. Thereafter, the public company would seek to raise additional capital through a private placement, using the proceeds to help finance the expansion if its hearing centers. In addition Mr. Srivastava intends to have the public company make appropriate filings with the Securities Exchange Commission to become subject to the reporting requirements of federal securities laws.

AHC was formed in 2004 by its founder Sanjay Srivastava and has grown rapidly. According to its unaudited financial statements revenues, gross profit and net income have increased steadily, as follows:

                        Fiscal 2006          Fiscal 2007          Fiscal 2008
                        -----------          -----------          -----------
                        (unaudited)          (unaudited)          (unaudited)

    Revenues            $1,560,229           $2,723,916           $3,083,056
    Gross Profit         1,061,658            1,985,280            2,118,275
    Net Income               3,812              105,654              108,715

Forward-Looking Statements: Statements in this new release regarding future financial and operating results, future expansion and growth, opportunities for the public company and any other statements about its future expectations, beliefs, goals, plans, or prospects constitute forward-looking statements within the meaning of the private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements, There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital and economic conditions generally. Forward-looking statements are based on the beliefs, opinions, and expectations of management at the time they are made, and the public company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.


'/>"/>
SOURCE SETO Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Innophos Holdings, Inc. Elects John M. Steitz as New Independent Director
2. China Pharma Holdings, Inc., Financial Year 2008 Preview
3. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 First Quarter Earnings Webcast
4. Z Trim Holdings, Inc. Releases Letter to Shareholders
5. Duane Reade Holdings, Inc. Further Strengthens Management Team With Addition of Frank Scorpiniti, SVP, Pharmacy Operations
6. Integrated Healthcare Holdings, Inc. Announces New Chief Executive Officer
7. The Hanover Insurance Group Completes Acquisition of AIX Holdings, Inc.
8. Critical Homecare Solutions Holdings, Inc. to Present at the 20th Annual Piper Jaffray Health Care Conference
9. Chief Executive Officer Leaving Integrated Healthcare Holdings, Inc.
10. China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates
11. Duane Reade Holdings, Inc. Reports Third Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... With over 16,000 ... bioidentical hormone replacement therapy and integrative medicine, has become a frontrunner for people ... such as menopause, andropause, thyroid disorder and adrenal insufficiencies. , Founded in ...
(Date:8/18/2017)... ... August 18, 2017 , ... 800response, the ... monitoring solutions, announced today the launch of a redesigned corporate website, 800response.com ... aesthetic, fully responsive design, and an enhanced search directory for businesses and advertising ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... “Beyond Our ... fulfilled life. “Beyond Our Imaginations: The Infinite God” is the creation of published author, ... across the country. , Lawrence shares, “The problem with becoming a greater man of ...
(Date:8/18/2017)... ... 18, 2017 , ... “Prompted By Love”: a love story thrown into doubt ... Nettles. Author Mary P. Nettles has devoted her life to ministry since the ... lifelong desire to write was, however, not fulfilled until 2014 when "The Color of ...
(Date:8/17/2017)... ... August 17, 2017 , ... Shared leadership between physicians ... effective, very effective, or effective by 85% of respondents, according to the recent ... Reports are based on surveys of the NEJM Catalyst Insights Council, a qualified ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... , Aug. 15, 2017 AccuGenomics, Inc., a ... , today announced that the company has provided an ... of North Carolina at Chapel Hill and to Qura ... to characterize and quantify HIV reservoir and viral expression ... intervention. The HIV Cure Center is a joint initiative ...
(Date:8/8/2017)... Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a ... reports its financial results for the second quarter ended ... the second quarter 2017 and to date: ... development programs for the Company,s lead project, BL-8040: ... study with BL-8040 as novel stem cell mobilization treatment ...
(Date:8/7/2017)... 7, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s ... ended June 30, 2017.  All comparisons, unless otherwise noted, are ... Second Quarter 2017 Highlights include: ... million, an increase of 3.5% Total prescriptions ... margin of 7.5% versus 7.6% Gross ...
Breaking Medicine Technology: